Tenax Therapeutics, Inc. (TENX) stock
TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.62+0.01 (+0.62%)
Close on Nov 13, 2026Market cap $60.63MP/E –Yield –
Tenax Therapeutics gross margin
Gross margin is gross profit as a percentage of revenue.
Tenax Therapeutics's gross margin for the twelve months ending Apr 30, 2015 was 0.0%. For fiscal 2015 it was 0.0%, against -65.5% the year before. The highest annual figure on record is 100.0% in fiscal 2011.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2015 | Apr 30, 2015 | 0.0% | +65.5 |
| FY2014 | Apr 30, 2014 | -65.5% | −69.6 |
| FY2013 | Apr 30, 2013 | 4.2% | −9.4 |
| FY2012 | Apr 30, 2012 | 13.5% | −86.5 |
| FY2011 | Apr 30, 2011 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2015CQ1 2015 | Apr 30, 2015 | 0.0% | – |
See a number that looks wrong?